Zivo Bioscience, Inc. Stock News

BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal an

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of

Zivo Bioscience Inc (ZIVO) shares closed today 11.1% higher than it did at the end of yesterday. The stock is currently down 15.0% year-to-date, up 1526.7% over the past 12 months, and up 1526.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $3.02 and as low as $2.37 this week.Shares closed 65.7% below its 52-week high and 12.0% above its 52-week low.Trading volume this week was 41.6% lower than the 10-day average and 63.8% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1359.4% The company's stock price performance over the past 12 months beats the peer average by 28505.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

ZIVO Bioscience (ZIVO) names current chairman John Payne as president and CEO.Payne succeeds Andrew Dahl.Payne has served as a member of ZIVO''s board since Jul

Zivo Bioscience Inc (ZIVO) shares closed today at 0.8% above its 52 week low of $2.42, giving the company a market cap of $22M. The stock is currently down 15.0% year-to-date, up 1526.7% over the past 12 months, and up 1526.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 68.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1359.4% The company's stock price performance over the past 12 months beats the peer average by 22058.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Zivo Bioscience Inc (ZIVO) shares closed today at 0.4% above its 52 week low of $2.72, giving the company a market cap of $25M. The stock is currently up 1720.0% year-to-date, up 1720.0% over the past 12 months, and up 1720.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 rose 0.3%. Trading Activity Trading volume this week was 3.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 25098.5% The company's stock price performance over the past 12 months beats the peer average by 29236.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 public companies in the Food & kindred products industry, but how does it weigh in compared to its peers? We will compare ZIVO Bioscience to related companies based on the strength of its dividends, earnings, institutional ownership, profitability, risk, analyst recommendations and valuation. Risk and Volatility ZIVO []

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 public companies in the Food & kindred products industry, but how does it contrast to its competitors? We will compare ZIVO Bioscience to related businesses based on the strength of its profitability, institutional ownership, analyst recommendations, valuation, dividends, earnings and risk. Risk & Volatility ZIVO Bioscience has []

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 public companies in the Food & kindred products industry, but how does it weigh in compared to its peers? We will compare ZIVO Bioscience to similar businesses based on the strength of its risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership. Profitability This table compares [] The post Analyzing ZIVO Bioscience (ZIVO) & Its Rivals appeared first on ETF Daily News .

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 publicly-traded companies in the Food & kindred products industry, but how does it compare to its competitors? We will compare ZIVO Bioscience to similar companies based on the strength of its dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations. Earnings and Valuation This table compares []

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 public companies in the Food & kindred products industry, but how does it compare to its competitors? We will compare ZIVO Bioscience to similar companies based on the strength of its dividends, risk, earnings, valuation, profitability, analyst recommendations and institutional ownership. Insider and Institutional Ownership 0.4% of []

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 public companies in the Food & kindred products industry, but how does it compare to its rivals? We will compare ZIVO Bioscience to similar companies based on the strength of its profitability, institutional ownership, valuation, dividends, risk, earnings and analyst recommendations. Insider and Institutional Ownership 0.4% of [] The post ZIVO Bioscience (ZIVO) and Its Peers Financial Comparison appeared first on ETF Daily News .

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 public companies in the Food & kindred products industry, but how does it weigh in compared to its peers? We will compare ZIVO Bioscience to related businesses based on the strength of its valuation, risk, analyst recommendations, dividends, institutional ownership, profitability and earnings. Profitability This table compares []

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 publicly-traded companies in the Food & kindred products industry, but how does it weigh in compared to its peers? We will compare ZIVO Bioscience to related companies based on the strength of its risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends. Profitability This table compares []

ZIVO Bioscience (OTCMKTS: ZIVO) is one of 31 public companies in the Food & kindred products industry, but how does it weigh in compared to its rivals? We will compare ZIVO Bioscience to similar businesses based on the strength of its earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Profitability This table compares []